|
ProMetic Life Sciences Inc. is a publicly traded (, ) biopharmaceutical company. ProMetic products are used in the purification of biologics, drug development, proteomics and the removal of pathogens. ProMetic uses its own technology for the extraction and purification of therapeutic proteins from human plasma, which are then used in the creation of therapeutics and orphan drugs. ProMetic also develops small-molecule therapeutic products for sufferers of fibrosis, cancer and autoimmune diseases. Headquartered in Laval, Quebec, ProMetic has: *Research and development facilities in the UK, the US and Canada *Manufacturing facilities in the UK and Canada〔(Emergent Biosolutions signs long term manufacturing agreement with ProMetic Life Sciences )〕 It also conducts business development activities in the US, Europe and Asia. As of 2015, it has approximately 250 employees. ==History== ProMetic was incorporated on October 14, 1994 under the Canada Business Corporations Act, originally as Innovon Life Sciences Holdings Limited. On May 19, 1998, the Corporation changed its name from Innovon Life Sciences Holdings Limited to ProMetic Life Sciences Inc. and went public through a listing on the Toronto Stock Exchange. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「ProMetic Life Sciences Inc.」の詳細全文を読む スポンサード リンク
|